Pines Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.34M Sell
9,209
-179
-2% -$24.7K 0.38% 72
2026
Q2
$1.21M Buy
9,388
+195
+2% +$22.8K 0.35% 78
2026
Q1
$1.11M Buy
9,193
+2,025
+28% +$234K 0.36% 77
2025
Q4
$755K Buy
7,168
+57
+0.8% +$5.35K 0.24% 97
2025
Q3
$597K Sell
7,111
-104
-1% -$8.57K 0.2% 115
2025
Q2
$584K Buy
7,215
+234
+3% +$18.6K 0.21% 115
2025
Q1
$551K Buy
6,981
+154
+2% +$14.4K 0.25% 99
2024
Q4
$678K Buy
+6,827
New +$704K 0.29% 88

Other funds holding MRK

Pines Wealth Management's MRK Position: Q3 2026 in Review

Pines Wealth Management reduced its Merck (MRK) stake by 1.9% in Q3 2026, selling an estimated $24.7K and leaving 9,209 shares worth $1.34M. The position accounts for 0.38% of the portfolio, ranked #72.

Pines Wealth Management first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,953 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Pines Wealth Management held 9,209 shares of Merck worth $1.34M as of Q3 2026.
  • Pines Wealth Management sold 179 Merck shares in Q3 2026, an estimated $24.7K.
  • Merck made up 0.38% of Pines Wealth Management's portfolio in Q3 2026, its #72 holding.
  • Pines Wealth Management first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 3,953 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Pines Wealth Management's 13F filing for Q3 2026, filed 21 Oct 2026.